A Study to Understand the Usefulness of Cotyledon umbilicus in reducing the pain of sciatica prescribed according to the symptoms given in The Encyclopedia of Pure Materia Medica

Phase 3

• Conditions: Health Condition 1: M543- Sciatica

• Registration Number: CTRI/2024/04/065536
• Lead Sponsor: Dr MPK Homoeopathic Medical College, Hospital and Research Centre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Patient giving consent for the study.

2.Patient having minimum 3 symptoms of the following of Cotyledon umbilicus mentioned in The Encyclopedia of Pure Materia Medica ? by T. F. Allen as follows:

? Aching bruised pain all over the lower limbs. She can scarcely walk for aching in the limbs, legs feel heavy and sore.

? Pain and stiffness of the right hip, going off after a walk, in the evening. Shooting pain, sudden and sharp, in the right infra gluteal region, felt principally on walking in the open air.

? Great aching of the hip joint, relieved by moving about. Continual soreness of the hip and thigh, posteriorly.

? Aching in the left thigh, posteriorly. Aching in the back part of the left thigh, with numbness. Stringing pain under the left gluteal maximus, in the region of great sciatic nerve

3.Diagnosed cases taking treatment from other system of medicine having no relief seeking homoeopathic treatment.

4.Undiagnosed cases will be enrolled after confirming the following criteria: -

? Straight Leg Raise (SLR) positive.

? Patient presenting with clinical features of pain radiating down the back to the extremities with positive result of one or more neurological examination indicating nerve root tension or neurological deficit and numbness of the limbs.

? Xray of Lumbosacral Region (PA and Lateral View).

Exclusion Criteria

1.Females those are pregnant or lactating.

2.Patient refusing or not willing to give consent for the study.

3.Patient suffering from severe systemic diseases.

4.Cases requiring emergency/surgical intervention.

5.Patient from other pharmacological intervention and are not willing to leave it.

Study & Design

• Study Type: Interventional
• Study Design: Not specified